Evidence map›Paper›PMID 29443550›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2018

Erythropoietin, a putative neurotransmitter during hypoxia, is produced in RVLM neurons and activates them in neonatal Wistar rats.

Naoki Oshima, Hiroshi Onimaru, Akira Yamagata, Seigo Itoh, Hidehito Matsubara, Toshihiko Imakiire, Yasuhiro Nishida, Hiroo Kumagai

Open access · hybridAbstract readComparative Study
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. SGLT2 and SGLT1 inhibitors suppress the activities of the RVLM neurons in newborn Wistar rats.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Editors' Picks for 2018 demonstrate the diversity of research in regulatory, integrative, and comparative physiology.American journal of physiology. Regulatory, integrative and comparative physiology · 2019
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Naoki OshimaDepartment of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Saitama , Japan.
Hiroshi OnimaruDepartment of Physiology, Showa University School of Medicine , Tokyo , Japan.
Akira YamagataDepartment of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Saitama , Japan.
Seigo ItohDepartment of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Saitama , Japan.
Hidehito MatsubaraDepartment of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Saitama , Japan.
Toshihiko ImakiireDepartment of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Saitama , Japan.
Yasuhiro NishidaDepartment of Physiology, National Defense Medical College, Tokorozawa, Saitama , Japan.
Hiroo KumagaiDepartment of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Saitama , Japan.
National Defense Medical College · JPShowa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies indicate that erythropoietin (EPO) is present in many areas of the brain and is active in the restoration of impaired neurons. In this study, we examined the presence of EPO and its role in bulbospinal neurons in the rostral ventrolateral medulla (RVLM). Hypoxia is often accompanied by a high blood pressure (BP). We hypothesized that EPO is produced in response to hypoxia in RVLM neurons and then activates them. To investigate whether RVLM neurons are sensitive to EPO, we examined the changes in the membrane potentials (MPs) of bulbospinal RVLM neurons using the whole cell patch-clamp technique during superfusion with EPO. A brainstem-spinal cord preparation was used for the experiments. EPO depolarized the RVLM neurons, and soluble erythropoietin receptor (SEPOR), an antagonist of EPO, hyperpolarized them. Furthermore, hypoxia-depolarized RVLM neurons were significantly hyperpolarized by SEPOR. In histological examinations, the EPO-depolarized RVLM neurons showed the presence of EPO receptor (EPOR). The RVLM neurons that possessed EPORs showed the presence of EPO and hypoxia-inducible factor (HIF)-2α. We also examined the levels of HIF-2α and EPO messenger RNA (mRNA) in the ventral sites of the medullas (containing RVLM areas) in response to hypoxia. The levels of HIF-2α and EPO mRNA in the hypoxia group were significantly greater than those in the control group. These results suggest that EPO is produced in response to hypoxia in RVLM neurons and causes a high BP via the stimulation of those neurons. EPO may be one of the neurotransmitters produced by RVLM neurons during hypoxia.

Indexed as

Action PotentialsAnimalsAnimals, NewbornBasic Helix-Loop-Helix ProteinsBlood PressureCell HypoxiaEndothelial PAS Domain-Containing Protein 1ErythropoietinHypertensionHypoxiaIn Vitro TechniquesMedulla OblongataNeuronsRats, WistarReceptors, ErythropoietinUp-RegulationBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1Erythropoietinerythropoietin, ratReceptors, ErythropoietinEPORerythropoietinHIF-2αhypoxiaRVLM neurons

Identifiers

PMID29443550
PMCPMC6008112
OpenAlexW2786641704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.